Log in or Sign up for Free to view tailored content for your specialty!
Gastroenterology News
‘Gold standard evidence’ supports use of probiotic blend to improve constipation
CHICAGO — Adults with occasional constipation reported significant improvement in stool consistency and GI-related symptoms after receiving a probiotic blend, results from a randomized study presented at NUTRITION showed.
‘Tremendous leap forward’: FDA approves first colorectal cancer blood test
The FDA has approved Guardant Health’s Shield blood test to screen for colorectal cancer in patients aged 45 years and older at average risk for disease, according to a company press release.
Log in or Sign up for Free to view tailored content for your specialty!
‘It’s time for action’: World Hepatitis Day calls to end an ‘entirely preventable disease’
Every year on July 28th, clinicians and researchers recognize World Hepatitis Day to bring awareness to one of the world’s deadliest but preventable viruses and continue efforts to meet the global goal of eliminating viral hepatitis by 2030
Q&A: Stool samples could help diagnose autism early, researchers say
Findings from a study that identified differences in the gut microbiota of children with autism indicate that stool sample testing could be used as an early, noninvasive diagnostic tool for autism, researchers reported.
Q&A: Risk for long COVID has declined, remains ‘substantial’
The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported.
Mayo Clinic ranks No. 1 in US for gastroenterology, GI surgery for 9th consecutive year
For the ninth consecutive year, the Mayo Clinic has been named the best hospital in the United States for gastroenterology and gastrointestinal surgery, according to the 2024-2025 U.S. News & World Report Best Hospitals rankings.
To initiate same-day hepatitis C testing and treatment, hepatitis B status must be known
The FDA’s recent authorization of a rapid, point-of-care test to diagnose current hepatitis C virus infection is a major victory, but it would be malpractice to initiate same-day HCV treatment if a patient’s hepatitis B virus status is unknown.
Q&A: Phenotype test predicting semaglutide response could ‘change conversation’ on obesity
In a Healio exclusive, Andres J. Acosta, MD, PhD, highlights data demonstrating that the MyPhenome test may serve as a biomarker to determine whether a patient with obesity will be a “good responder” to semaglutide.
Healio seeks nominees for Disruptive Innovators Awards in gastroenterology
Healio will present its seventh annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.
FDA approves biosimilar Pyzchiva for all approved Stelara indications
The FDA has approved the Stelara biosimilar Pyzchiva for psoriatic arthritis, Crohn’s disease and all other indications approved for the reference medicine, according to a press release from Sandoz.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read